Abstract:Objective: Cancer is a complex genetic disease characterized by the accumulation of various mutations, with driver genes playing a crucial role in cancer initiation and progression. Distinguishing driver genes from passenger mutations is essential for understanding cancer biology and discovering therapeutic targets. However, the majority of existing methods ignore the mutational heterogeneity and commonalities among patients, which hinders the identification of driver genes more effectively. Methods: This study introduces MCSdriver, a novel computational model that integrates network and pathway information to prioritize the identification of cancer driver genes. MCSdriver employs a bidirectional random walk algorithm to quantify the mutual exclusivity and functional relationships between mutated genes within patient cohorts. It calculates similarity scores based on a mutual exclusivity-weighted network and pathway coverage patterns, accounting for patient-specific heterogeneity and molecular profile similarity. Results: This approach enhances the accuracy and quality of driver gene identification. MCSdriver demonstrates superior performance in identifying cancer driver genes across four cancer types from The Cancer Genome Atlas, showing a higher F-score, Recall and Precision compared to existing ranking list-based and module-based models. Conclusion: The MCSdriver model not only outperforms other models in identifying known cancer driver genes but also effectively identifies novel driver genes involved in cancer-related biological processes. The model's consideration of patient-specific heterogeneity and similarity in molecular profiles significantly enhances the accuracy and quality of driver gene identification. Validation through Gene Ontology enrichment analysis and literature mining further underscores its potential application value in personalized cancer therapy, offering a promising tool for advancing our understanding and treatment of cancer.

CFC: a Cascade Forest Approach to Discover Cancer Driver Genes Using Multi-Omics Data.

Identification of Cancer Driver Modules by Combining Network Functional and Topology Information.

A feature extraction framework for discovering pan‐cancer driver genes based on multi‐omics data

Enhancing Cancer Driver Gene Prediction by Protein-Protein Interaction Network

DrGaP: a powerful tool for identifying driver genes and pathways in cancer sequencing studies.

Discovery of Pan-Cancer Related Genes Via Integrative Network Analysis.

Identification of Cancer Driver Modules Based on Graph Clustering from Multiomics Data

Identification of Common Driver Gene Modules and Associations between Cancers through Integrated Network Analysis

Identifying Cancer Specific Driver Modules Using A Network-Based Method

Identifying Hepatocellular Carcinoma Driver Genes by Integrative Pathway Crosstalk and Protein Interaction Network

Identification of Cancer Driver Genes by Integrating Multiomics Data with Graph Neural Networks

From multi-omics data to the cancer druggable gene discovery: a novel machine learning-based approach

PathDriver: Cancer Driver Genes Identification Based on the Metabolic Pathway

Cooperative Driver Module Identification Based on Single Cell Data

DriverFinder: A Gene Length-Based Network Method to Identify Cancer Driver Genes

Advancing cancer driver gene identification through an integrative network and pathway approach

DriverOmicsNet: An Integrated Graph Convolutional Network for Multi-Omics Exploration of Cancer Driver Genes

Effects of Multi-Omics Characteristics on Identification of Driver Genes Using Machine Learning Algorithms.

Identifying Cancer Patient Subgroups by Finding Co-Modules from the Driver Mutation Profiles and Downstream Gene Expression Profiles

RWCFusion: Identifying Phenotype-Specific Cancer Driver Gene Fusions Based on Fusion Pair Random Walk Scoring Method

A Cancer Gene Module Mining Method Based on Bio-Network of Multi-Omics Gene Groups